Amplia Therapeutics

(OTC) INNMF

Current Price$0.09

Market Cap$66.70M

Since IPO (2016)-17%

5 Year-40%

1 Year+274%

1 Month-30%

Amplia Therapeutics Financials at a Glance

Market Cap

$66.70M

Revenue (TTM)

$5.79M

Net Income (TTM)

$13.95M

EPS (TTM)

$-0.01

P/E Ratio

-10.08

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$0.09

Volume

8,750

Open

$0.09

Price

$0.09

Volume

8,750

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.03 - $0.27

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$0.09

Volume

8,750

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.03 - $0.27

INNMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amplia Therapeutics

Industry

Biotechnology

Sector

Health Care

CEO

Christopher J. Burns, PhD

Website

www.ampliatx.com

Headquarters

Melbourne, VIC 3000, AU

INNMF Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

-5%

Net Income Margin

-3%

Return on Equity

-27%

Return on Capital

-25%

Return on Assets

-18%

Earnings Yield

-9.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$66.70M

Shares Outstanding

513.07M

Volume

8.75K

Avg. Volume

11.44K

Financials (TTM)

Gross Profit

$3.57M

Operating Income

$6.52M

EBITDA

$6.78M

Operating Cash Flow

$6.89M

Capital Expenditure

$2.07K

Free Cash Flow

$6.89M

Cash & ST Invst.

$10.86M

Total Debt

$13.89K

Amplia Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$36.30K

-101.5%

Gross Margin

0.00%

N/A

Market Cap

$66.70M

N/A

Market Cap/Employee

$66.70M

N/A

Employees

N/A

Net Income

$4.00M

-254.2%

EBITDA

$6.96M

-99.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$28.48M

+733.5%

Accounts Receivable

$6.40M

+78.0%

Inventory

$0.00

N/A

Long Term Debt

$595.19K

+982.4%

Short Term Debt

$83.84K

-96.2%

Return on Assets

-17.81%

N/A

Return on Invested Capital

-24.88%

N/A

Free Cash Flow

$8.00M

-125.8%

Operating Cash Flow

$8.00M

-125.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CVALFCovalon Technologies Ltd.

CVALFCovalon Technologies Ltd.$1.38-1.03%

ACHFFArch Biopartners Inc.

ACHFFArch Biopartners Inc.$0.32-0.64%

OTLCOncotelic Therapeutics, Inc.

OTLCOncotelic Therapeutics, Inc.$0.04-1.01%

ZIVOZIVO Bioscience, Inc.

ZIVOZIVO Bioscience, Inc.$3.55-6.58%

RLFTFMindMaze Therapeutics Holding S.A.

RLFTFMindMaze Therapeutics Holding S.A.$0.45+9.62%

HBPCFHelix BioPharma Corp.

HBPCFHelix BioPharma Corp.$1.73+0.00%

PSYBFPsyBio Therapeutics Corp.

PSYBFPsyBio Therapeutics Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

Questions About INNMF

What is the current price of Amplia Therapeutics?

Amplia Therapeutics is trading at $0.09 per share.

What is the 52-week range for Amplia Therapeutics?

Over the past 52 weeks, Amplia Therapeutics has traded between $0.03 and $0.27.

How much debt does Amplia Therapeutics have?

As of the most recent reporting period, Amplia Therapeutics reported total debt of $8,657.423.

How much cash does Amplia Therapeutics have on hand?

Amplia Therapeutics reported $6.77M in cash and cash equivalents in its most recent financial results.

What is Amplia Therapeutics’s dividend yield?

Amplia Therapeutics does not currently have a dividend yield.

Amplia Therapeutics

Amplia Therapeutics Financials at a Glance

INNMF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Amplia Therapeutics

INNMF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Amplia Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About INNMF

What is the current price of Amplia Therapeutics?

What is the 52-week range for Amplia Therapeutics?

How much debt does Amplia Therapeutics have?

How much cash does Amplia Therapeutics have on hand?

What is Amplia Therapeutics’s dividend yield?

Premium Investing Services